SUPPLEMENTAL FIGURE. Global estimated coverage with 3 doses of diphtheria-tetanus-pertussis vaccine, by country† and gross national income (GNI) per capita
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

SUPPLEMENTAL FIGURE. Global estimated coverage with 3 doses of diphtheria-tetanus-pertussis vaccine, by country† and gross national income (GNI) per capita
  • Published Date:

    November 18, 2016

  • Source:
    Casey RM, Dumolard L, Danovaro-Holliday MC, et al. Global Routine Vaccination Coverage, 2015. MMWR Morb Mortal Wkly Rep 2016;65:1270–1273. DOI: http://dx.doi.org/10.15585/mmwr.mm6545a5.
  • Language:
    English
Filetype[PDF-225.12 KB]


Details:
No Related Documents.

You May Also Like:

  1. Filetype[PDF - 175.92 KB]
    Personal Author:
    Peck, Megan; Gacic-Dobo, Marta; Diallo, Mamadou S.; Nedelec, Yoann; Sodha, Samir S.; Wallace, Aaron S.;
    Published Date:
    October 25 2019
    Source:
    MMWR Morb Mortal Wkly Rep. 68(42):937-942
    Description:
    Endorsed by the World Health Assembly in 2012, the Global Vaccine Action Plan 2011-2020 (GVAP) (1) calls on all countries to reach ≥90% national coverage with all vaccines in the country's national immunization schedule by 2020. Building on previou...
    File Type:
    Filetype[PDF - 175.92 KB]
  2. Filetype[PDF - 118.51 KB]
    Personal Author:
    Chard, Anna N.; Gacic-Dobo, Marta; Diallo, Mamadou S.; Sodha, Samir V.; Wallace, Aaron S.;
    Published Date:
    November 13 2000
    Source:
    MMWR Morb Mortal Wkly Rep. 69(45):1706-1710
    Description:
    Endorsed by the World Health Assembly in 2020, the Immunization Agenda 2030 strives to reduce morbidity and mortality from vaccine-preventable diseases across the life course (1). This report, which updates previous reports (2), presents global, regi...
    File Type:
    Filetype[PDF - 118.51 KB]
  3. Filetype[PDF - 536.19 KB]
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    October 25, 2019
    Series:
    MMWR. Morbidity and mortality weekly report ; v. 68, no. 42
    File Type:
    Filetype[PDF - 536.19 KB]
  4. Filetype[PDF - 373.85 KB]
    Personal Author:
    Dabbagh, Alya; Laws, Rebecca L.; Steulet, Claudia; Dumolard, Laure; Mulders, Mick N.; Kretsinger, Katrina; Alexander, James P.; Rota, Paul A.; Goodson, James L.;
    Published Date:
    Nov 30 2018
    Source:
    MMWR Morb Mortal Wkly Rep. 67(47):1323-1329
    Description:
    In 2010, the World Health Assembly set three milestones for measles prevention to be achieved by 2015: 1) increase routine coverage with the first dose of measles-containing vaccine (MCV1) among children aged 1 year to ≥90% at the national level an...
    File Type:
    Filetype[PDF - 373.85 KB]
  5. Filetype[PDF - 310.60 KB]
    Personal Author:
    Wang, Susan A.; Mantel, Carsten F.; Gacic-Dobo, Marta; Dumolard, Laure; Cherian, Thomas; Flannery, Brendan; Loo, Jennifer D.; Verani, Jennifer R.; Whitney, Cynthia G.;
    Published Date:
    Apr 26 2013
    Source:
    MMWR Morb Mortal Wkly Rep. 2013; 62(16):308-311.
    Description:
    Pneumococcal conjugate vaccines (PCVs) are safe and effective for reducing illness and deaths caused by Streptococcus pneumoniae. Recommendations for PCV use from the World Health Organization (WHO) and funding from the GAVI Alliance have resulted in...
    File Type:
    Filetype[PDF - 310.60 KB]